Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SDX-105 (Bendamustine) in Rituximab-Refractory Indolent NHL
NCT00069758Phase 2Completed
- Sponsor
- Cephalon, Inc.
- Start
- Sep 2003
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bendamustine in B-cell non-Hodgkin lymphoma, sponsored by Cephalon, Inc.. Started Sep 2003; status: completed.
02
Drugs
bendamustine
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00069758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069758.